Latest total liabilities for GRNAW: $92M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
GreenLight Biosciences- Warrants (30/09/2027) (GRNAW) currently reports a total liabilities of $92M as of March 2023. That compares with $59M in the prior-year period — up 56.6% year over year. Use the charts on this page to explore GreenLight Biosciences- Warrants (30/09/2027)'s total liabilities history and peer comparisons.
GreenLight Biosciences- Warrants (30/09/2027)'s total liabilities increased from $59M to $92M — a 56.6% year-over-year increase (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
GreenLight Biosciences- Warrants (30/09/2027) reported $92M in total liabilities as of March 2023. That compares with $59M in the prior-year period — up 56.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total liabilities of $92M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GreenLight Biosciences- Warrants (30/09/2027), and consider following GRNAW for alerts when major investors trade the stock.